Доказательно о травах. Научный подход к фитотерапии

33. Swanson CA. Suggested guidelines for articles about botanical dietary supplements. Am J Clin Nutr 2002;75:8-10. [PubMed abstract]

34. Office of Dietary Supplements, National Institutes of Health. Dietary Supplement Analytical Methods and Reference Materials Program (AMRM).

35. Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. Am J Obstet Gynecol 2008;199:455-66. [PubMed abstract]

36. Teschke R, Schwarzenboeck A, Schmidt-Taenzer W, Wolff A, Hennermann KH. Herb induced liver injury presumably caused by black cohosh: a survey of initially purported cases and herbal quality specifications. Ann Hepatol 2011;10:249-59. [PubMed abstract]

37. National Center for Complementary and Alternative Medicine, Office of Dietary Supplements. Workshop on the safety of black cohosh in clinical studies. 2004.

38. Jiang B, Kronenberg F, Nuntanakorn P, Qiu MH, Kennelly EJ. Evaluation of the botanical authenticity and phytochemical profile of black cohosh products by high-performance liquid chromatography with selected ion monitoring liquid chromatography-mass spectrometry. J Agric Food Chem 2006;54:3242-53. [PubMed abstract]

39. Health Canada. Black cohosh products and liver toxicity: update. 2010.

40. Australian Government Department of Health, Therapeutic Goods Administration. New labelling requirements and consumer information for medicines containing black cohoshexternal link disclaimer. 2007.

41. Mahady GB, Low Dog T, Barrett ML, Chavez ML, Gardiner P, Ko R, et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008;15:628-38.

42. Ших Е.В., Махова А.А., Ших Н.В., Марин Т.В., Жукова О.В. Выбор фитоэстрогенов и конструирование рациональных комбинаций с микронутриентами у пациенток в перименопаузе. Вопросы гинекологии, акушерства и перинатологии. 2023; 22(1): 83–90. DOI: 10.20953/1726-1678-2023-1-83-90

43. Ших ЕВ, Махова АА. Соединения природного происхождения в купировании симптомов и снижении рисков перименопаузального периода. Медицинский Совет. 2023;(15):94-103. https://doi.org/10.21518/ms2023-352

44. Roberts H., Lethaby A. Phytoestrogens for menopausal vasomotor symptoms: A Cochrane review summary. Maturitas. 2014;78:79–81. doi: 10.1016/j.maturitas.2014.04.004

45. Булаев В.М., Ших Е.В., Сычев Д.А. Безопасность и эффективность лекарственных растений Издательство Практическая медицина. Год издания 2013. Страниц 272.

46. Laakmann E., Grajecki D., Doege K., Zu Eulenburg C., Bühling K.J. Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: A systematic review. Gynecol. Endocrinol. 2012;28:703–709. doi: 10.3109/09513590.2011.650772. [PubMed] [CrossRef] [Google Scholar]

47. Liu Y.-R., Jiang Y.-L., Huang R.-Q., Yang J.-Y., Xiao B.-K., Dong J.-X. Hypericum perforatum L. preparations for menopause: A meta-analysis of efficacy and safety. Climacteric. 2014;17:325–335. doi: 10.3109/13697137.2013.861814.

ГЛАВА 11

1. González-Burgos E, Liaudanskas M, Viškelis J, Žvikas V, Janulis V, Gómez-Serranillos MP. Antioxidant activity, neuroprotective properties and bioactive constituents analysis of varying polarity extracts from Eucalyptus globulus leaves. J Food Drug Anal. 2018 Oct;26(4):1293–1302. doi: 10.1016/j.jfda.2018.05.010. Epub 2018 Jun 18. PMID: 30249328; PMCID: PMC9298563.

2. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr. 2012 Feb;95(2):454-64. doi: 10.3945/ajcn.111.016634. Epub 2012 Jan 4. PMID: 22218162; PMCID: PMC326

3. Fischer J, Dethlefsen U. Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial. Cough. 2013 Nov 21;9(1):25. doi: 10.1186/1745-9974-9-25. PMID: 24261680; PMCID: PMC3842692.

4. Juergens UR, Dethlefsen U, Steinkamp G, Gillissen A, Repges R, Vetter H. Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respir Med. 2003 Mar;97(3):250-6. doi: 10.1053/rmed.2003.1432. PMID: 12645832.

5. Sadlon AE, Lamson DW. Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices. Altern Med Rev. 2010 Apr;15(1):33–47. PMID: 20359267.

6. Jun YS, Kang P, Min SS, Lee JM, Kim HK, Seol GH. Effect of eucalyptus oil inhalation on pain and inflammatory responses after total knee replacement: a randomized clinical trial. Evid Based Complement Alternat Med. 2013;2013:502727. doi: 10.1155/2013/502727. Epub 2013 Jun 18. PMID: 23853660; PMCID: PMC3703330.

7. De Vincenzi M, Silano M, De Vincenzi A, Maialetti F, Scazzocchio B. Constituents of aromatic plants: eucalyptol. Fitoterapia. 2002 Jun;73(3):269-75. doi: 10.1016/s0367-326x(02)00062-x. PMID: 12048025.